The role of the Hippo pathway in heart disease

FEBS J. 2022 Oct;289(19):5819-5833. doi: 10.1111/febs.16092. Epub 2021 Jul 12.

Abstract

Heart disease, including coronary artery disease, myocardial infarction, heart failure, cardiac hypertrophy, and cardiomyopathies, is the leading causes of death worldwide. The Hippo pathway is a central controller for organ size and tissue growth, which plays a pivotal role in determining cardiomyocytes and nonmyocytes proliferation, regeneration, differentiation, and apoptosis. In this review, we summarize the effects of the Hippo pathway on heart disease and propose potential intervention targets. Especially, we discuss the molecular mechanisms of the Hippo pathway involved in maintaining cardiac homeostasis by regulating cardiomyocytes and nonmyocytes function in the heart. Based on this, we conclude that the Hippo pathway is a promising therapeutic target for cardiovascular therapy, which will bring new perspectives for their treatments.

Keywords: Hippo pathway; cardiac hypertrophy; cardiomyopathy; coronary artery disease; heart failure; myocardial infarction.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heart Diseases* / genetics
  • Heart Diseases* / metabolism
  • Hippo Signaling Pathway*
  • Humans
  • Myocytes, Cardiac / metabolism
  • Protein Serine-Threonine Kinases / genetics
  • Regeneration / physiology
  • Signal Transduction / physiology

Substances

  • Protein Serine-Threonine Kinases